Results 141 to 150 of about 1,259,858 (300)

Performance and robustness analysis reveals phenotypic trade-offs in yeast [PDF]

open access: yes
To design strains that can function efficiently in complex industrial settings, it is crucial to consider their robustness, that is, the stability of their performance when faced with perturbations.
Olsson, Lisbeth   +5 more
core   +1 more source

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

open access: yesMolecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens   +6 more
wiley   +1 more source

Multigroup Robustness

open access: yesCoRR
To address the shortcomings of real-world datasets, robust learning algorithms have been designed to overcome arbitrary and indiscriminate data corruption. However, practical processes of gathering data may lead to patterns of data corruption that are localized to specific partitions of the training dataset. Motivated by critical applications where the
Lunjia Hu   +2 more
openaire   +3 more sources

Trust and Growth in the 1990s: A Robustness Analysis [PDF]

open access: yes
We conduct an extensive robustness analysis of the relationship between trust and growth for a later time period (the 1990s) and with a bigger sample (63 countries) than previous studies.
Berggren, Niclas   +2 more
core  

Towards Analyzing Semantic Robustness of Deep Neural Networks

open access: yes, 2019
implementation of the paper: "Towards Analyzing Semantic Robustness of Deep Neural Networks" (ECCV 2020 ...
Abdullah Hamdi   +3 more
core   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Robust Vision

open access: yesProcedings of the British Machine Vision Conference 1994, 1994
Torr, P, Beardsley, P, Murray, D
openaire   +3 more sources

Network robustness: Implication, formulization and exploitation [PDF]

open access: yes, 2016
Robustness refers to a system's capacity for maintaining some performance when the system's internal structure is perturbed. In previous study, network robustness, i.e., network structure robustness, includes both resistance capacity (connection ...
WenJun Zhang
core  

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

open access: yesMolecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy